| dc.contributor.author |
Gebremedhin, Melat |
|
| dc.date.accessioned |
2025-03-27T07:53:02Z |
|
| dc.date.available |
2025-03-27T07:53:02Z |
|
| dc.date.issued |
2024-06 |
|
| dc.identifier.citation |
Submitted by iphce iphce (iphce-e@gmail.com) on 2025-03-27T07:53:02Z
No. of bitstreams: 0 |
en_US |
| dc.identifier.citation |
Made available in DSpace on 2025-03-27T07:53:02Z (GMT). No. of bitstreams: 0
Previous issue date: 2024-06 |
en_US |
| dc.identifier.uri |
https://etd.aau.edu.et/items/a2b125a4-c90e-4ae7-8c16-4d5394d7a1d9 |
|
| dc.description.abstract |
Ethics in the conduct of clinical research is mandatory to protect research
participants. The goal of phase І clinical trial is to determine the maximum dose of the new
medication that may be administered without the risk of serious side effects. Participants in most
of phase І clinical trial have no direct benefit in participating in the trial but the amount of money
provided for compensation can cause the participants to participate without being concerned to
the risks the new drug may bring. |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.subject |
Traditional health care & alternative therapies |
|
| dc.title |
Assessing safety and ethical issues among participants in a herbal medicine phase І clinical trial: conducted in Addis Ababa Ethiopia: A Mixed Methods Research |
en_US |
| dc.title.alternative |
Assessing safety and ethical issues among participants in a herbal medicine phase –Ü clinical trial: conducted in Addis Ababa Ethiopia: A Mixed Methods Research |
en_US |
| dc.type |
Thesis |
S |
| dc.type |
Thesis |
en_US |